Combining immunotherapy with radiation therapy in thoracic oncology | Zendy

Shahed N. Badiyan | Zendy; Michael Roach | Zendy; Michael D. Chuong | Zendy; Stephanie R. Rice | Zendy; N. Onyeuku | Zendy; Jill Remick | Zendy; Srinivas Chilukuri | Zendy; Erica Glass | Zendy; Pranshu Mohindra | Zendy; Charles B. Simone | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Combining immunotherapy with radiation therapy in thoracic oncology

Author(s) -

Shahed N. Badiyan,

Michael Roach,

Michael D. Chuong,

Stephanie R. Rice,

N. Onyeuku,

Jill Remick,

Srinivas Chilukuri,

Erica Glass,

Pranshu Mohindra,

Charles B. Simone

Publication year - 2018

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2018.05.73

Subject(s) - medicine , immunotherapy , radiation therapy , oncology , clinical trial , lung cancer , radiation oncology , targeted therapy , cancer

Thoracic malignancies comprise some of the most common and deadly cancers. Immunotherapies have been proven to improve survival outcomes for patients with advanced non-small cell lung cancer (NSCLC) and show great potential for patients with other thoracic malignancies. Radiation therapy (RT), an established and effective treatment for thoracic cancers, has acted synergistically with immunotherapies in preclinical studies. Ongoing clinical trials are exploring the clinical benefits of combining RT with immunotherapies and the optimal manner in which to deliver these complementary treatments.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research